ProteoNic and NecstGen Establish Partnership to Improve Viral Vector Manufacturing Efficiency for Gene Therapies

ProteoNic and NecstGen announce a partnership for the development of improved viral vector manufacturing for gene therapy applications. Both companies, located on the Leiden Bio Science Park, recognise the need to increase viral titres and optimise production processes.

Related Keywords

Boston ,Massachusetts ,United States ,Science Park ,Netherlands ,Mark Posno ,Paul Bilars ,Frank Pieper ,Tristan Pritchard Meaker ,Head Of Business Development ,Business Development ,Gene Therapy ,Leiden Bio Science Park ,Gene Therapies ,Leiden Bio Science ,Pharmaceutical Preparations ,Regenerative Medicine ,Genetic Therapy ,Genetic Vectors ,Biological Products ,Proteonic ,Ecstgen ,Partnership ,Viral Vector Manufacturing ,Dmo ,G Unic Technology ,